Nicolas Pottier

2.7k total citations
54 papers, 1.5k citations indexed

About

Nicolas Pottier is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Nicolas Pottier has authored 54 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 18 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Nicolas Pottier's work include MicroRNA in disease regulation (12 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Circular RNAs in diseases (7 papers). Nicolas Pottier is often cited by papers focused on MicroRNA in disease regulation (12 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Circular RNAs in diseases (7 papers). Nicolas Pottier collaborates with scholars based in France, United States and Austria. Nicolas Pottier's co-authors include Christelle Cauffiez, François Glowacki, Michaël Perrais, Jean‐Marc Lo‐Guidice, Viviane Gnemmi, Cynthia Van der Hauwaert, Bernard Mari, Grégoire Savary, Sébastien Aubert and Pascal Barbry and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Nicolas Pottier

52 papers receiving 1.5k citations

Peers

Nicolas Pottier

PRM

ONCOL

NEPHR

Laura Necula Romania

Wenjie Wang China

Weijie Yuan China

Dong Xue China

Marisa Cañadas‐Garre Spain

Alberto Benito‐Martín Spain

Jian Geng China

Shotaro Naito Japan

Ningzheng Dong China

Laura Necula Romania

Nicolas Pottier

563 ×0.7

333 ×0.6

285 ×1.2

PRM

293 ×1.7

ONCOL

216 ×1.4

NEPHR

Citations per year, relative to Nicolas Pottier Nicolas Pottier (= 1×) peers Laura Necula

Countries citing papers authored by Nicolas Pottier

Since Specialization

Citations

This map shows the geographic impact of Nicolas Pottier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Pottier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Pottier more than expected).

Fields of papers citing papers by Nicolas Pottier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Pottier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Pottier. The network helps show where Nicolas Pottier may publish in the future.

Co-authorship network of co-authors of Nicolas Pottier

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Pottier. A scholar is included among the top collaborators of Nicolas Pottier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Pottier. Nicolas Pottier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pottier, Nicolas, et al.. (2025). Exon location of glycine substitutions impacts kidney survival in autosomal dominant Alport syndrome. Nephrology Dialysis Transplantation. 40(8). 1522–1530.

Lemaire, J., Cynthia Van der Hauwaert, Grégoire Savary, et al.. (2020). Cadmium-Induced Renal Cell Toxicity Is Associated With MicroRNA Deregulation. International Journal of Toxicology. 39(2). 103–114. 21 indexed citations

Lionet, Arnaud, Viviane Gnemmi, Christelle Cauffiez, et al.. (2020). Diagnostic utility of whole-genome sequencing for nephronophthisis. npj Genomic Medicine. 5(1). 38–38. 11 indexed citations

Hamroun, Aghilès, Jean Joël Bigna, Élodie Speyer, et al.. (2019). Prevention of Cisplatin-Induced Acute Kidney Injury: A Systematic Review and Meta-Analysis. Drugs. 79(14). 1567–1582. 62 indexed citations

Maanaoui, Mehdi, Aghilès Hamroun, Cynthia Van der Hauwaert, et al.. (2019). Caveolin-1 rs4730751 single-nucleotide polymorphism may not influence kidney transplant allograft survival. Scientific Reports. 9(1). 15541–15541. 1 indexed citations

Boyer, Thomas, Adeline Barthélémy, Alice Marceau‐Renaut, et al.. (2019). Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive Study. Cancers. 11(9). 1323–1323. 29 indexed citations

Savary, Grégoire, Nicolas Pottier, Bernard Mari, & Christelle Cauffiez. (2019). La fonction d’un long ARN non codant décodée dans la fibrose pulmonaire idiopathique. médecine/sciences. 35(10). 739–742. 1 indexed citations

Bertero, Thomas, Roger Rezzonico, Nicolas Pottier, & Bernard Mari. (2017). Impact of MicroRNAs in the Cellular Response to Hypoxia. International review of cell and molecular biology. 333. 91–158. 41 indexed citations

Buob, David, Cynthia Van der Hauwaert, Viviane Gnemmi, et al.. (2016). miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy. Scientific Reports. 6(1). 27209–27209. 67 indexed citations

10.

Hauwaert, Cynthia Van der, Grégoire Savary, Claire Pinçon, et al.. (2015). Donor caveolin 1 (CAV1) genetic polymorphism influences graft function after renal transplantation. PubMed. 8(1). 8–8. 10 indexed citations

11.

Ranchin, Bruno, et al.. (2015). Xanthinurie héréditaire de type 1 : à propos de trois cas. Archives de Pédiatrie. 22(12). 1288–1291. 4 indexed citations

12.

Savary, Grégoire, Matthieu Buscot, Edmone Dewaeles, et al.. (2014). MiR-214-3p, a new fibromiR involved in the pathogenesis of idiopathic pulmonary fibrosis. European Respiratory Journal. 44(Suppl 58). 1731–1731. 4 indexed citations

13.

Pottier, Nicolas, Christelle Cauffiez, Michaël Perrais, Pascal Barbry, & Bernard Mari. (2014). FibromiRs: translating molecular discoveries into new anti-fibrotic drugs. Trends in Pharmacological Sciences. 35(3). 119–126. 70 indexed citations

14.

Bertero, Thomas, Karine Robbe-Sermesant, Kévin Le Brigand, et al.. (2014). MicroRNA Target Identification: Lessons from HypoxamiRs. Antioxidants and Redox Signaling. 21(8). 1249–1268. 13 indexed citations

15.

Glowacki, François, Grégoire Savary, Viviane Gnemmi, et al.. (2013). Increased Circulating miR-21 Levels Are Associated with Kidney Fibrosis. PLoS ONE. 8(2). e58014–e58014. 171 indexed citations

16.

Cheok, Meyling, Nicolas Pottier, Leo Kager, & William E. Evans. (2008). Pharmacogenetics in Acute Lymphoblastic Leukemia. Seminars in Hematology. 46(1). 39–51. 52 indexed citations

17.

Pottier, Nicolas, Meyling Cheok, & Leo Kager. (2008). Antileukemic drug effects in childhood acute lymphoblastic leukemia. Expert Review of Clinical Pharmacology. 1(3). 401–413. 1 indexed citations

18.

Pottier, Nicolas, Meyling Cheok, Wentao Yang, et al.. (2007). Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter snp that alters PARP1 binding and SMARCB1 expression. Human Molecular Genetics. 16(19). 2261–2271. 34 indexed citations

19.

Pottier, Nicolas, Virginie Defamie, Bruno Cardinaud, et al.. (2007). Relationships between Early Inflammatory Response to Bleomycin and Sensitivity to Lung Fibrosis. American Journal of Respiratory and Critical Care Medicine. 176(11). 1098–1107. 16 indexed citations

20.

Cauffiez, Christelle, Gilles Tournel, Delphine Allorge, et al.. (2004). Functional characterization of genetic polymorphisms identified in the human cytochrome P450 4F12 (CYP4F12) promoter region. Biochemical Pharmacology. 67(12). 2231–2238. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact